Who
Peter DeMuth
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, Elicio Therapeutics.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Feb 2024
- Last trade
- 16 Jul 2026
- Last filed
- 17 Jul 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Jul 2026filed 17 Jul 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,832 at $0.00 | filing |
| 16 Jul 2026filed 17 Jul 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —52,832 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,800 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,600 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —41,600 at $0.00 | filing |
| 2 Feb 2026filed 3 Feb 2026 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,800 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —362 at $0.00 | filing |
| 9 Dec 2025filed 10 Dec 2025 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Code M | $1,596362 at $4.41 | filing |
| 3 Feb 2025filed 4 Feb 2025 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —44,400 at $0.00 | filing |
| 16 Dec 2024filed 18 Dec 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —381 at $0.00 | filing |
| 16 Dec 2024filed 18 Dec 2024 | ELTX Elicio TherapeuticsBiotechnology | SEC FORM 4 Code M | $1,680381 at $4.41 | filing |
| 30 Sep 2024filed 2 Oct 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,800 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,800 at $0.00 | filing |
| 1 Feb 2024filed 5 Feb 2024 | ELTX Elicio Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —342 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.